However, it has been reported that enzalutamide promotes prostate cancer metastasis in different models [22, 23], moreover, in our study we found that AR knockdown promotes invasion and migration of prostate cancer cells while DANCR knockdown reduces the promotion. This evidence concerns the gene AR and Familial prostate cancer.